Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04191499 |
|---|---|
| Brief Title: | A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative, Locally Advanced or Metastatic Breast Cancer (INAVO120) |
| First Submitted : | December 2, 2019 |
| First Submitted that Met QC Criteria : | December 6, 2019 |
| First Posted : | December 9, 2019 |
| Last Update Submitted that Met QC Criteria : | April 25, 2024 |
| Last Update Posted : | April 26, 2024 |